PURPOSE: Patients undergoing hemodialysis (HD) present persistent inflammation and protein-energy wasting (PEW), which contributes to high rates of mortality. This study aimed to assess the effects of a resistance exercise training program (RETP) on inflammation and PEW in HD patients. METHODS: Thirty-seven patients (56.7 % men, 45.9 ± 14.1 years, 23.5 ± 3.9 kg/m(2)) performed 6 months of intradialytic RETP. Plasma adhesion molecules levels (ICAM-1 and VCAM-1) were measured using the enzyme immunometric assay, and interleukin-6 (IL-6), C-reactive protein, and tumor necrosis factor-alpha by ELISA. Anthropometric, physical capacity, and PEW (simultaneously presence of: BMI <23 kg/m(2), serum albumin <3.8 g/dL, and reduced arm muscle area) were analyzed. RESULTS: There was a reduction of ICAM-1 [(1,934.1 pg/mL (1,031.8-2,875.0) vs. 1,571.1 pg/mL (447.1-2,985.5), p < 0.05], VCAM-1 [5,259.51 pg/mL (3,967.4-6,682.4) vs. 3,062.11 pg/mL (2,034.0-5,034.4), p < 0.05], and CRP levels (2.3 ± 0.9 to 1.6 ± 0.6 pg/mL, p < 0.001) after 6 months of RETP. Body composition improved, albumin increased (3.7 ± 0.3 to 3.9 ± 0.2, p < 0.05), and the number of patients presenting PEW was decreased (p = 0.005). CONCLUSIONS: Resistance exercise program for 6 months seems to be effective in reducing inflammation and PEW of HD patients. The universal trial number of this study is U1111-1139-1326.
PURPOSE:Patients undergoing hemodialysis (HD) present persistent inflammation and protein-energy wasting (PEW), which contributes to high rates of mortality. This study aimed to assess the effects of a resistance exercise training program (RETP) on inflammation and PEW in HDpatients. METHODS: Thirty-seven patients (56.7 % men, 45.9 ± 14.1 years, 23.5 ± 3.9 kg/m(2)) performed 6 months of intradialytic RETP. Plasma adhesion molecules levels (ICAM-1 and VCAM-1) were measured using the enzyme immunometric assay, and interleukin-6 (IL-6), C-reactive protein, and tumor necrosis factor-alpha by ELISA. Anthropometric, physical capacity, and PEW (simultaneously presence of: BMI <23 kg/m(2), serum albumin <3.8 g/dL, and reduced arm muscle area) were analyzed. RESULTS: There was a reduction of ICAM-1 [(1,934.1 pg/mL (1,031.8-2,875.0) vs. 1,571.1 pg/mL (447.1-2,985.5), p < 0.05], VCAM-1 [5,259.51 pg/mL (3,967.4-6,682.4) vs. 3,062.11 pg/mL (2,034.0-5,034.4), p < 0.05], and CRP levels (2.3 ± 0.9 to 1.6 ± 0.6 pg/mL, p < 0.001) after 6 months of RETP. Body composition improved, albumin increased (3.7 ± 0.3 to 3.9 ± 0.2, p < 0.05), and the number of patients presenting PEW was decreased (p = 0.005). CONCLUSIONS: Resistance exercise program for 6 months seems to be effective in reducing inflammation and PEW of HDpatients. The universal trial number of this study is U1111-1139-1326.
Authors: Peter Stenvinkel; Markus Ketteler; Richard J Johnson; Bengt Lindholm; Roberto Pecoits-Filho; Miguel Riella; Olof Heimbürger; Tommy Cederholm; Matthias Girndt Journal: Kidney Int Date: 2005-04 Impact factor: 10.612
Authors: Juan Jesús Carrero; Peter Stenvinkel; Lilian Cuppari; T Alp Ikizler; Kamyar Kalantar-Zadeh; George Kaysen; William E Mitch; S Russ Price; Christoph Wanner; Angela Y M Wang; Pieter ter Wee; Harold A Franch Journal: J Ren Nutr Date: 2013-03 Impact factor: 3.655
Authors: Carmen Castaneda; Patricia L Gordon; Russell C Parker; Katherine Leigh Uhlin; Ronenn Roubenoff; Andrew S Levey Journal: Am J Kidney Dis Date: 2004-04 Impact factor: 8.860
Authors: Johanna Ihalainen; Simon Walker; Gøran Paulsen; Keijo Häkkinen; William J Kraemer; Mari Hämäläinen; Katriina Vuolteenaho; Eeva Moilanen; Antti A Mero Journal: Eur J Appl Physiol Date: 2014-08-22 Impact factor: 3.078
Authors: Aurel Zelko; Ivana Skoumalova; Peter Kolarcik; Jaroslav Rosenberger; Miroslava Rabajdova; Maria Marekova; Andrea Madarasova Geckova; Jitse P van Dijk; Sijmen A Reijneveld Journal: Medicine (Baltimore) Date: 2019-05 Impact factor: 1.817
Authors: Erika Meléndez Oliva; Jorge H Villafañe; Jose Luis Alonso Pérez; Alexandra Alonso Sal; Guillermo Molinero Carlier; Andrés Quevedo García; Silvia Turroni; Oliver Martínez-Pozas; Norberto Valcárcel Izquierdo; Eleuterio A Sánchez Romero Journal: J Pers Med Date: 2022-07-21